Stoke Therapeutics Inc
NASDAQ:STOK

Watchlist Manager
Stoke Therapeutics Inc Logo
Stoke Therapeutics Inc
NASDAQ:STOK
Watchlist
Price: 33.09 USD -3.1% Market Closed
Market Cap: 1.9B USD

Wall Street
Price Targets

STOK Price Targets Summary
Stoke Therapeutics Inc

Wall Street analysts forecast STOK stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STOK is 32.26 USD with a low forecast of 24.24 USD and a high forecast of 40.95 USD.

Lowest
Price Target
24.24 USD
27% Downside
Average
Price Target
32.26 USD
3% Downside
Highest
Price Target
40.95 USD
24% Upside
Stoke Therapeutics Inc Competitors:
Price Targets
CLYM
Climb Bio Inc
308% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
34% Upside
2616
CStone Pharmaceuticals
142% Upside
ARGX
argenx SE
12% Upside
VTVT
vTv Therapeutics Inc
11% Upside
ANAB
AnaptysBio Inc
34% Upside
PASG
Passage Bio Inc
278% Upside

Revenue
Forecast

Revenue Estimate
Stoke Therapeutics Inc

The compound annual growth rate of Stoke Therapeutics Inc's revenue for the next 3 years is 19%.

N/A
Past Growth
19%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Stoke Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Stoke Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is STOK's stock price target?
Price Target
32.26 USD

According to Wall Street analysts, the average 1-year price target for STOK is 32.26 USD with a low forecast of 24.24 USD and a high forecast of 40.95 USD.

What is Stoke Therapeutics Inc's Revenue forecast?
Projected CAGR
19%

The compound annual growth rate of Stoke Therapeutics Inc's revenue for the next 3 years is 19%.

Back to Top